Close

Fameccanica’s Patent Stands Against Challenge By Curt G. Joa, Inc.

fameccanicapressrelease.jpg

On October 11, 2017, in its Final Written Decision in inter partes review number IPR2016-00906, the United States Patent Trial and Appeal Board (“PTAB”) upheld the validity of all of the claims of Fameccanica’s U.S. Patent No. 6,994,761, entitled “Disposable Absorbent Garment such as a diaper or training pants and a process of making the same.” 

In its petition, Joa alleged that other patents prior in time to Fameccanica’s U.S. Patent No. 6,994,761 disclosed the invention claimed in Fameccanica’s patent: “a breathable, stretchable layer assembly including an inner material layer, an outer material layer and a stretchable material layer disposed there between and including vent sites which are formed by ultrasonic bonding of the inner and outer material layers through the stretchable material layer”.

The PTAB found the Curt G. Joa’s allegations to be meritless, as earlier anticipated by Fameccanica in its April 27, 2016 press release and, since Curt G. Joa failed to prove that any claims of Fameccanica’s patent are invalid, upheld the validity of Fameccanica’s U.S. Patent No. 6,994,761.

Fameccanica is a worldwide leader in the design and manufacture of hygienic disposable absorbent products converting machinery and has been a persistent innovator since it was founded in 1975.  Fameccanica.Data S.R.L. a Socio Unico is the founder of the Fameccanica Group with operations in Europe, Asia, North America, and South America, and the center of excellence for the development and design of all the Fameccanica technological platforms and for the production of top performing, high innovation level machines.  

Fameccanica owns over 600 pending and granted patents protecting many of the innovative solutions it provides in the hygienic disposable absorbent products converting industry.  As it has done in the past, Fameccanica will continue to take a resolute stand against the infringement of any of its patents, and will continue to defend its patents against meritless allegations of invalidity.